U.S. Airlines Stock News

Global trade is under fresh scrutiny as U.S. authorities target a vast “shadow” transshipment network that is linked to an estimated $19b to $26b in lost tariff revenue and a modeled $113b to $150b hit to GDP. That kind of policy focus can reshuffle winners and losers across logistics and 3PL operators. This article examines three stocks exposed to this crackdown and discusses how the new rules could shape their risk and reward profile. The stocks that follow are just a small sample of the...

Q2 2026 earnings put Berkshire Hathaway stock back in focus Berkshire Hathaway (BRK.A) drew fresh attention after reporting Q2 2026 results on August 8, with revenue of US$101.8b and net income of US$25.7b for the quarter. For the first half of 2026, Berkshire Hathaway reported revenue of US$195.5b and net income of US$35.8b. Basic earnings per share from continuing operations reached US$24,889 for the six month period. See our latest analysis for Berkshire Hathaway. The latest earnings...

Globant walked into this earnings season with a reputation as a high growth digital transformation and artificial intelligence partner. The stock had gained over the last month, then gave up ground with an 8.8% drop to US$37.38 after the Q2 report. That move indicates sentiment shifted quickly. The results present a more nuanced story. Revenue for Q2 came in at US$614.4m and basic earnings per share fell to about US$0.04. The main headline is profit pressure, including a US$32.3m one time...

In early August 2026, Snap Inc. reported second-quarter 2026 results showing sales of US$1,598.99 million and a net loss of US$163.96 million, with both revenue and per-share losses improving compared with a year earlier. At the same time, growing concern over a potential nationwide school smartphone ban has raised fresh questions about Snap’s reliance on teen ad engagement during school hours. Next, we’ll examine how the prospect of a nationwide school smartphone ban could reshape Snap’s...

KinderCare Learning Companies just saw its stock collapse 46% in a single session, which indicates that emotions are in charge. The headline from the earnings is not a revenue air pocket. Revenue for the quarter landed at US$698 million, only slightly below last year, and adjusted earnings per share came in positive at US$0.08. The main friction point is sentiment colliding with a loss-making trailing year, thin free cash flow guidance below US$10 million, and a low 0.1x P/S multiple that...

Addus HomeCare recently announced that President and COO Heather Dixon has left the company, with former President and COO Brad Bickham returning as interim Chief Operating Officer for one year, alongside reporting second-quarter 2026 net income of US$27.61 million and diluted EPS of US$1.49, both higher than a year earlier. This combination of leadership reshuffling and stronger profitability highlights how Addus is leaning on experienced operators while generating more earnings from its...

Honeywell International stock has fallen about 40.3% year to date, yet the valuation checks suggest a mixed picture rather than a simple bargain or clear overpricing. The share price is down 40.3% year to date, which puts the recent weakness in focus for investors assessing whether the current level reflects company fundamentals. The recent separation of Honeywell Aerospace and its own updated long term outlook may support expectations for future cash flows. At the same time, execution risks...

Kontoor Brands (NYSE:KTB) plans to sell its Lee brand to Authentic Brands Group in a deal valued at up to US$1b. The company intends to focus its portfolio on Wrangler and Helly Hansen as its core growth drivers after the transaction. Management expects the Lee sale to be immaterial to near term earnings per share, with proceeds earmarked for redeployment. This type of brand portfolio reshaping is not unique to Kontoor Brands, so it can be useful to compare it with other companies exposed...

In early August 2026, Blue Bird Corporation reported third-quarter sales of US$517.16 million and net income of US$185.26 million, raised its full-year 2026 net revenue outlook to US$1.75 billion, and outlined a long-term collaboration with Ford to design and manufacture next-generation F-53/F-59 commercial stripped chassis starting in 2028. By combining much stronger profitability, a higher full-year revenue target, and a deeper Ford partnership that broadens its commercial vehicle reach,...

Westinghouse Air Brake Technologies (WAB) is back in focus after recent share price moves, with the stock last closing at $299.02. Investors are weighing this performance against the company’s current financial profile. See our latest analysis for Westinghouse Air Brake Technologies. The recent 1-month share price return of 15.14% and year to date share price return of 38.26% suggest momentum in Westinghouse Air Brake Technologies is building, while the 1-year total shareholder return of...

Sterling Infrastructure, Inc. reported past second‑quarter 2026 results with sales rising to US$1,168.18 million and net income to US$155.83 million, and management raised full‑year 2026 guidance to revenue of US$4.00–US$4.15 billion and diluted EPS of US$17.25–US$17.85 while continuing to seek acquisitions. Management highlighted a larger pipeline of high-quality acquisition targets and strong backlog and phase opportunities in areas like data centers and semiconductors, reinforcing the...

Xunlei stock barely flinched after earnings, inching up about 2% to US$5.25, which suggests traders are treating this quarter as business as usual. The headline is anything but routine. Revenue reached about US$102 million as the consumer pivot in subscriptions and overseas audio live streaming took hold, yet a large loss tied to a long term investment dragged reported net income deep into the red. Across a week the stock is slightly higher, though it is still down over the past month and...

Ascendis Pharma stock barely flinched after earnings, up less than 1% around €248 even though the headline numbers were anything but quiet. Q2 revenue landed at €339.3m and basic earnings per share came in at €3.22, keeping the trailing twelve month profit story intact. Traders may see a tired chart after a weak month. Long term investors are staring at a company that has just shifted from years of losses to €741.8m in net income over the last four reported quarters, with a deep late stage...

Centene stock has delivered a very strong 136.8% return over the past year, yet the latest valuation checks still suggest the shares lean cheap rather than fully priced. Over the last 12 months Centene has returned 136.8%, which puts extra focus on whether today's buyers are paying too much for that rebound. Raised expectations for future revenue and earnings may support the current share price, while execution risks around Medicaid margin recovery and managed care profitability could still...

SS Innovations International stock barely budged after earnings, up about 1.6% to US$3.89. The latest quarter reinforced the existing narrative: this is a high-growth medical equipment stock with meaningful losses and a tight cash runway, trading on a rich sales multiple. The headline from Q2 is straightforward. Revenue reached about US$13.9m while the company again reported a net loss of roughly US$2.7m. Investors now need to decide whether the current premium P/S multiple and less than one...

First Bank stock barely moved after earnings, inching up to US$19.02, which suggests the market shrugged at the headline. The numbers point to a more detailed story. Quarterly earnings per share of about US$0.44 and net income of roughly US$10.9m sit inside a trailing price to earnings ratio of 11.1x. That is below both the wider US banks sector and close peers. The notable point is a quietly profitable lender that appears discounted on valuation while investors debate how much growth to...

HawkEye 360 came into this earnings print with a rich story stock reputation and a volatile share price, then promptly lost 6.5% today. The selloff sits awkwardly next to what the company just posted. Revenue for the latest quarter reached US$49.8 million, with signals intelligence demand in both U.S. and international markets feeding an 87% year on year gain. The real headline is profitability pressure, not growth. Adjusted EBITDA landed at US$7.0 million, while the company swung to a GAAP...

Boston Scientific stock is down about 49.8% over the past year, yet the current checks suggest the shares may now sit at a discount to what the company’s cash flows imply. Both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiples are pointing to Boston Scientific trading below what these models consider a fair value. Over the last year the share price declined 49.8%, which puts recent weakness and sentiment at odds with models that indicate the stock may now be...

Sudden changes to tariff rules on low value imports are rewiring the cost equation for goods coming into the U.S., and that matters directly for stocks tied to domestic production. As de minimis exemptions fade and policy risk around trade grows, some companies may gain breathing room while import heavy rivals feel the squeeze. This article walks through three U.S. manufacturers that appear positioned on the positive side of that shift. The three stocks covered below are only a small sample...

Melco Resorts & Entertainment stock barely flinched after earnings, edging about 2% higher to around US$5.60. The market reaction looked calm for a casino operator that just reported a sharp squeeze in quarterly profitability. Net income fell to US$22.7m in Q2 on US$1.25b of revenue, with basic earnings per share slipping to US$0.06. The near term snapshot looks soft. The bigger question is whether investors focus on this margin pressure or on a business that, over the past year, has reported...

FitLife Brands shares slipped about 3.5% to US$10.80 after Q2 numbers hit the tape, which suggests sentiment moved faster than the headline figures. The stock entered the release with a slightly positive three-month return, so today’s drop stands out. The core story is not a collapse in earnings. Revenue reached US$26.5m and net income came in at US$2.0m, supported by the Irwin acquisition. The main point of concern is sentiment around margins, with gross margin at 37.0% as investors weigh...

Earlier this week, Rezolve AI launched Rezolve Provenance, a patent-backed, model-agnostic platform that marks, signs and verifies AI-generated or modified content across enterprise and commerce workflows, including C2PA Content Credentials, embedded image watermarking, secure provenance records and verification APIs. An interesting angle is that Rezolve Provenance directly targets new EU AI Act transparency rules on machine-readable marking of AI content, positioning the platform as...

Amaroq stock barely flinched after its Q2 release, slipping just 0.4% today, even though the report marked a clear sentiment break from the company’s loss making past. The market kept its cool while Amaroq posted Q2 revenue of C$37.3m and net income of C$11.1m, turning what had been a story of build out into one of cash generation. The real headline is the earnings swing. Trailing twelve month Basic EPS has moved into positive territory, backed by first half gross profit of C$34.9m. Price...

CorMedix went into this print with a value story and a low P/E multiple that had already caught investor attention. The stock still dropped 7.4% to close near US$7.54 after the report. This suggests that emotion is running ahead of the headline numbers. The quarter itself was not a collapse story. CorMedix posted Q2 revenue of US$101.9m and net income of US$25.8m, and management raised full year adjusted EBITDA guidance to a range of US$125m to US$140m. That creates a clear expectation gap...